Navigation Links
Siemens Customers Innovate Their Clinical and Financial Workflows with Help from Soarian
Date:11/19/2007

MALVERN, Pa., Nov. 19 /PRNewswire/ -- Siemens Medical Solutions (http://www.usa.siemens.com/healthcareit) continues to help hospitals and healthcare systems innovate their clinical and financial workflows through Soarian(R), its next-generation, workflow-engineered healthcare information system. At the 93rd Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA) from Nov. 25 to 30 at McCormick Place in Chicago (Booth #7713, Hall B), Siemens will showcase the many benefits Soarian can bring to healthcare facilities across the globe.

(Logo: http://www.newscom.com/cgi-bin/prnh/20070904/SIEMENSLOGO )

Soarian combines clinical, financial and operational processes to support patient-centered care. By streamlining access to images and data from a variety of medical modalities in one location, Soarian helps facilitate more informed decision-making -- leading to improved care delivery, increased staff satisfaction, and more efficient business practices. In addition to helping streamline critical information across clinical, financial and administrative functions, Soarian is assisting many healthcare organizations in improving workflow and patient safety.

Last year, CentraState Healthcare System, a not-for-profit, 272-bed medical facility located in Freehold, N.J., embarked on a project to develop metrics and document and validate workflow outcomes in specific areas that would result from the use of Soarian. The project included a focus on reducing nosocomial pressure ulcer rates. Implementation of the Pressure Ulcer Prevention Workflow, driven by Soarian, enabled the CentraState nursing team to automate several key process steps and helped reduce the prevalence of nosocomial pressure ulcers in one year from a pre-workflow rate of 4.93 percent to a post-workflow rate
'/>"/>

SOURCE Siemens Medical Solutions
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Siemens and Xintek Form Joint Venture to Develop Nanotechnology-Enabled Multi-Pixel X-ray Tubes
2. MedAssets Supply Chain Systems Selects Siemens Medical Solutions Diagnostics for Chemistry, Automation and Immunoassay Solutions
3. Siemens Receives EU Antitrust Clearance for Acquisition of Dade Behring
4. Siemens Completes Acquisition of Dade Behring
5. Siemens Expands the SOMATOM Definition(TM) Line With Worlds First Adaptive CT Scanner
6. IMPAC Medical Systems to Offer Revenue Cycle Inc.s Array of Oncology Products and Services to Customers
7. New Survey Reveals Many Adults With High Cholesterol Fail to Take Necessary Steps to Improve Their Condition
8. Actress Aida Turturro Tells Americans to Start Now to Talk With Their Healthcare Provider About Taking Control of Their Diabetes
9. National Survey Shows Most Women Are Not Satisfied With Their Progesterone Treatment
10. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
11. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)... Aug. 20, 2014 Clintrax Global, Inc., ... in Raleigh, NC , recently ... as Vice President of Administration. ... all corporate processes, including their alignment with company ... Brad worked as an HR executive, specializing in ...
(Date:8/20/2014)... it that American Indians largely were wiped out by ... tuberculosis brought to the New World by European explorers., ... people lived in the Americas shortly before Europeans arrived, ... European diseases., But new research led by anthropological geneticists ... of the University of Tubingen in Germany indicates the ...
(Date:8/20/2014)... Fla. , Aug. 20, 2014 ... will host a conference call to provide an ... 2014Time:4:30 p.m. Eastern daylight timeDial-in numbers:(888) 505-4369 (U.S. ... 9126599 Live web cast: www.neurotropebioscience.com , under "Investor ... hours after completion through September 2, 2014 at ...
(Date:8/20/2014)... Aug. 20, 2014  Decision Resources Group finds that the vascular ... Russia , India and ... 2013, roughly equal to the size of the United ... market will experience much faster growth as a result of strong ... Other key findings from Decision Resources Group,s coverage of the ...
Breaking Biology Technology:Clintrax Global, Inc. Announces Addition to Executive Team 2Unusual discovery leads to fascinating tuberculosis theory 2Unusual discovery leads to fascinating tuberculosis theory 3Neurotrope To Host Conference Call 2BRIC Vascular Access Device Market Valued at $1.6 Billion in 2013, Similar to the U.S. Market 2BRIC Vascular Access Device Market Valued at $1.6 Billion in 2013, Similar to the U.S. Market 3
... -- Peregrine Pharmaceuticals, Inc. (NASDAQ: PPHM) today reported ... that supports the broad anti-viral potential of the ... its PS-targeting drug bavituximab can cure lethal virus ... Bavituximab is in clinical trials for the treatment ...
... ILE ) today announced that on March ... "Exchange") notifying the Company it is not in compliance ... "Company Guide"). Specifically, the Exchange staff noted that the ... to its overall operations or its existing financial sources ...
... Oncolytics Biotech Inc. (TSX: ONC, NASDAQ: ONCY ... I/II U.K. trial of REOLYSIN(R) combined with paclitaxel/carboplatin for ... International Meeting on Replicating Oncolytic Virus Therapeutics. The meeting ... to 22nd, 2009. The principal investigator for the trial ...
Cached Biology Technology:Nature Medicine study shows Peregrine's bavituximab can cure lethal virus infections 2Nature Medicine study shows Peregrine's bavituximab can cure lethal virus infections 3Isolagen, Inc. Receives Notification Letter from Amex 2Isolagen, Inc. Receives Notification Letter from Amex 3Isolagen, Inc. Receives Notification Letter from Amex 4Oncolytics Biotech(R) Inc. Collaborators Present Positive Head and Neck Results in Phase I/II Combination REOLYSIN(R) and Paclitaxel/Carboplatin Trial 2Oncolytics Biotech(R) Inc. Collaborators Present Positive Head and Neck Results in Phase I/II Combination REOLYSIN(R) and Paclitaxel/Carboplatin Trial 3
(Date:8/21/2014)... team of researchers at Louisiana Tech University ... affordable, consumer-grade 3D printers and materials to ... antibacterial and chemotherapeutic compounds for targeted drug ... students and research faculty from Louisiana Tech,s ... to create filament extruders that can make ...
(Date:8/21/2014)... itself resulting in severe abdominal pain, vomiting and systemic ... are diagnosed with the disease resulting in 1000 deaths. ... to intravenous fluid and nutritional support. , Dr ... led the research, said "The major causes of pancreatitis ... alcohol intake combined with a high fat diet. In ...
(Date:8/20/2014)... CITY Researchers at Huntsman Cancer Institute (HCI) at the ... of the gene that encodes BCR-ABL, the unregulated enzyme ... to the American Cancer Society, nearly 6,000 new cases ... already in use, called tyrosine kinase inhibitors (TKIs), target ... do not cure CML but control it in a ...
Breaking Biology News(10 mins):Louisiana Tech University researchers use 3D printers to create custom medical implants 2Louisiana Tech University researchers use 3D printers to create custom medical implants 3Insulin offers new hope for the treatment of acute pancreatitis 2Blueprint for next generation of chronic myeloid leukemia treatment 2
... symptom of physical pain or stress. But now a ... showing that tears have emotional benefits and can make ... Hasson of TAU,s Department of Zoology shows that tears ... an evolution-based mechanism to bring people closer together. ...
... by climate scientists at the University of East Anglia (UEA) ... field in the last two years. The article, ,Tipping ... Proceedings of the National Academy of Sciences in ... Paper, by Thomson Reuters. "The article captures the zeitgeist ...
... female cells counteract their double dose of X chromosomes by coating ... binds to the same X chromosome from which it is transcribed ... silencing. In the August 24, 2009 issue of the Journal ... the fact that XIST temporarily dissociates from the X chromosome during ...
Cached Biology News:Trust in a teardrop 2Tipping elements remain a 'hot' issue 2Tipping elements remain a 'hot' issue 3Aurora B answers an XIST-ential question 2
... With 36 mg/L sodium pyruvate, 50 mg/L ... mg/L glucose, calcium chloride, and magnesium chloride. ... (BSS) in tissue culture is generally attributed ... 1885, Sydney Ringer developed a solution of ...
... enables you to identify over 150 ... distinguish protein isoforms, protein subsets, and ... visualize peptide-protein associations and relationships easily. ... identification and relative protein expression analysis ...
... The B1 series embodies all aspects of ... microscope. With powerful Achromatic Super Contrast (ASC) ... imaging chip, this microscope combines flexibility and ... Motic's popular B1 series, the DM-B1 steps ...
... a high-throuput screening of a biological systems ... induced changes in the expression levels of ... detected, studied, classified and compared to each ... at a glance. Automatized scanning of the ...
Biology Products: